Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

05 Dec, 2018, 09:00 GMT Feraccru®, a Novel, Effective and Well Tolerated Treatment for Iron Deficiency Launched in the UK by Norgine

Feraccru®, a novel, effective and well tolerated treatment for iron deficiency (ID) with or without anaemia including treatment of iron deficiency...


05 Dec, 2018, 07:00 GMT Moorfields Dubai Performs Complex High-risk Surgery to Bring Maths Professor Back From the Brink of Blindness

Moorfields Eye Hospital Dubai (Moorfields Dubai) has performed a complex and high-risk surgical procedure as a last resort to prevent a patient...


04 Dec, 2018, 14:02 GMT Multiple Sclerosis (MS) Market Analysis, Market size, Epidemiology, Leading Companies and Competitive Analysis by DelveInsight

The market of Multiple Sclerosis (MS) in 7MM was found to be USD 21,248 million in 2016, and is expected to increase in 2027. Multiple Sclerosis (MS) ...


04 Dec, 2018, 12:05 GMT Migraine Drugs Market Size Worth $7.8 Billion by 2025 | CAGR: 18.0%: Grand View Research, Inc.

The global migraine drugs market size is expected to be valued at USD 7.8 billion by 2025, as per a new report by Grand View Research, Inc.,...


04 Dec, 2018, 08:00 GMT Is Christmas Causing Unnecessary Headache? New Survey Findings Shed Insight on the Stresses of the Festive Season Which May Be a Leading Cause of Headaches During the Run-up to Christmas[1]

As many as 8 out of 10 people have occasional tension-type headache[2] New data from OnePoll reveals that for a quarter of sufferers, the excesses of ...


04 Dec, 2018, 03:00 GMT Nordic Nanovector: Additional Preclinical Studies With CD37-targeting Radioimmunotherapies for B-cell Malignancies Presented at ASH

Nordic Nanovector ASA (OSE: NANO) notes that two new poster presentations from preclinical studies with CD37-targeting radioimmunotherapies were made ...


03 Dec, 2018, 16:29 GMT Interim Data from the Ongoing HORIZON Trial with Melflufen Presented in an Oral Presentation at the 60th American Society of Hematology Meeting

Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that Professor Paul G. Richardson presented updated interim data with melflufen (Ygalo®)...


03 Dec, 2018, 15:00 GMT Comprehensive Analyses from Pivotal Phase 3 QuANTUM-R Study Demonstrate Consistent Overall Survival Benefit of Daiichi Sankyo's FLT3 Inhibitor Quizartinib in Patients with Relapsed/Refractory FLT3-ITD AML

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced comprehensive analyses of overall survival from the pivotal QuANTUM-R phase 3...


03 Dec, 2018, 10:27 GMT Grünenthal Closes Deal With AstraZeneca for Nexium and Vimovo

Grünenthal today announced the successful completion of its acquisition of European rights to Nexium and global (ex US and Japan) rights to Vimovo...


03 Dec, 2018, 10:18 GMT Provacan CBD Becomes Britain's First Kosher Certified Cannabis Product

Provacan, UK's leading CBD oil provider, announced today that it has become Britain's first cannabis product to be certified as kosher by the KLBD...


03 Dec, 2018, 08:27 GMT Arix Bioscience plc: Autolus Announces Update on AUTO4 and AUTO5 Programmes

Arix Bioscience plc (LSE: ARIX) ("Arix"), a global healthcare and life science company supporting medical innovation notes its portfolio company,...


03 Dec, 2018, 08:25 GMT Arix Bioscience plc: Autolus Presents Initial AUTO3 Clinical Data at ASH

Arix Bioscience plc (LSE: ARIX) ("Arix"), a global healthcare and life science company supporting medical innovation notes that its portfolio...


03 Dec, 2018, 08:00 GMT Michelson Diagnostics: Imaging Reveals Changes in Blood Vessel Growth in Deadly Melanoma Skin Cancer

A new clinical study has shown that Dynamic Optical Coherence Tomography imaging of melanomas (D-OCT) reveals changes to the blood vessels that...


03 Dec, 2018, 03:14 GMT Nordic Nanovector: Single Administration Betalutin® is Effective and Well-tolerated in R/R iNHL Patients: 6 Month Follow-up Data Presented at ASH

Overall response rate (ORR) of 61% and complete response (CR) rate of 28% in 74 patients with indolent non-Hodgkin's lymphoma (iNHL) Highly active in ...


03 Dec, 2018, 03:01 GMT Anders Lönner, Chairman of the Board Karo Pharma AB, has Suddenly Passed Away

"It is with great regret and sadness we announce this very tragic and unexpected information", says the Board of Directors, Karo Pharma. "Anders...


03 Dec, 2018, 02:52 GMT BerGenBio Reports 43% Response Rate With Bemcentinib Monotherapy in AXL Positive R/R AML/MDS Patients at ASH

43% CR/CRi/CRp rate with bemcentinib monotherapy reported in AXL biomarker positive R/R AML/MDS patients (6 out of 14) Phase II trial continues in...


03 Dec, 2018, 02:50 GMT Finnish Blood Testing Scale-up and Health Service Provider Introduce Healthcare for the 21st Century - Connecting Molecular Medicine With Lifestyle Habits

Pioneering blood testing company, Nightingale Health, and Finnish wellbeing service provider Aava Virta, have launched Virta 360 - a unique health...


02 Dec, 2018, 14:14 GMT Oncopeptides Presents First Interim Data From the Ongoing Combination Trial ANCHOR With Melflufen at the 60th American Society of Hematology Meeting

Overall conclusions The combinations of melflufen and dexamethasone (dex) with either bortezomib or daratumumab in relapsed-refractory multiple...


30 Nov, 2018, 19:02 GMT CannTrust Dominates 2018 Canadian Cannabis Awards With Seven Wins Including LP of the Year

CannTrust Holdings Inc. ("CannTrust" or the "Company") (TSX: TRST), one of Canada's leading and most trusted licensed producers of cannabis, is...


30 Nov, 2018, 10:00 GMT Altered Microbiome After Caesarean Section Impacts Baby's Immune System, Research by Luxembourg Centre for Systems Biomedicine (LCSB) Finds

Together with colleagues from Sweden and Luxembourg, scientists from the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of...


30 Nov, 2018, 07:55 GMT Mundipharma CEO Raman Singh Wins Global Executive of the Year -- For Private Pharma Companies at Industry-Leading Scrip Awards

Mundipharma CEO, Raman Singh, has won Executive of the Year -- For Small Cap & Private Pharma Companies at the annual Scrip Awards, which were held...


29 Nov, 2018, 21:22 GMT SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Halozyme Therapeutics, Inc. - HALO

Pomerantz LLP is investigating claims on behalf of investors of Halozyme Therapeutics, Inc. ("Halozyme" or the "Company") (NASDAQ: HALO). Such...


29 Nov, 2018, 13:30 GMT Therachon is granted Orphan Drug Designation in the European Union for Apraglutide for the Treatment of Short Bowel Syndrome

Therachon AG ("Therachon"), a clinical-stage biotechnology company focused on treating the root causes of rare conditions, today announced that the...


29 Nov, 2018, 05:00 GMT MSD, MSD Animal Health and Novonordisk Egypt Awarded the Best Places To Work Certification in Egypt for 2018

MSD, MSD Animal Health and Novo Nordisk Egypt were awarded the Best Place To Work certification in Egypt for 2018, according to the annual Workplace...


28 Nov, 2018, 22:45 GMT Buvidal® Weekly and Buvidal® Monthly (CAM2038) Approved in Australia as the First Long-acting Treatment of Opioid Dependence

Camurus announced today that the Australian Therapeutic Goods Administration (TGA) has approved the company's lead products Buvidal® Weekly and...